← All trials
NCT03726736
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 21, 2018
- Primary completion
- Nov 1, 2019
- Completion date
- Nov 1, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 97
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Zhejiang UniversityLead sponsor
- Ningbo No. 2 HospitalCollaborator
- Zhejiang UniversityCollaborator
- Zhejiang UniversitySponsor investigator
- Chinese Academy of Medical SciencesCollaborator
- Ningbo No. 1 HospitalCollaborator
- Jiaxing Maternity and Child Health Care HospitalCollaborator
- Huzhou UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.